A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
This report contains market size and forecasts of Biopharmaceutical Buffers in global, including the following market information:
Global Biopharmaceutical Buffers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Biopharmaceutical Buffers Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Biopharmaceutical Buffers companies in 2021 (%)
The global Biopharmaceutical Buffers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sterile Buffer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceutical Buffers include GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Sartorius StedimBiotech, Merck, Eppendorf, Roche, Nova Biomedicals and Lonza, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biopharmaceutical Buffers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceutical Buffers Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biopharmaceutical Buffers Market Segment Percentages, by Type, 2021 (%)
Sterile Buffer
Non-sterile Buffer
Global Biopharmaceutical Buffers Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biopharmaceutical Buffers Market Segment Percentages, by Application, 2021 (%)
Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics
Other
Global Biopharmaceutical Buffers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biopharmaceutical Buffers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biopharmaceutical Buffers revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biopharmaceutical Buffers revenues share in global market, 2021 (%)
Key companies Biopharmaceutical Buffers sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Biopharmaceutical Buffers sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton, and Dickinson and Company
GEA